201 related articles for article (PubMed ID: 37352885)
21. Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.
Horn B; Cowan MJ
J Allergy Clin Immunol; 2013 May; 131(5):1306-11. PubMed ID: 23622119
[TBL] [Abstract][Full Text] [Related]
22. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I
J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725
[TBL] [Abstract][Full Text] [Related]
23. Eliminating SCID row: new approaches to SCID.
Kohn DB
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):475-80. PubMed ID: 25696897
[TBL] [Abstract][Full Text] [Related]
24. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases.
Fernandes JF; Nichele S; Arcuri LJ; Ribeiro L; Zamperlini-Netto G; Loth G; Rodrigues ALM; Kuwahara C; Koliski A; Trennepohl J; Garcia JL; Daudt LE; Seber A; Gomes AA; Fasth A; Pasquini R; Hamerschlak N; Rocha V; Bonfim C
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1923-1929. PubMed ID: 32653621
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
26. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
27. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.
Hassan A; Booth C; Brightwell A; Allwood Z; Veys P; Rao K; Hönig M; Friedrich W; Gennery A; Slatter M; Bredius R; Finocchi A; Cancrini C; Aiuti A; Porta F; Lanfranchi A; Ridella M; Steward C; Filipovich A; Marsh R; Bordon V; Al-Muhsen S; Al-Mousa H; Alsum Z; Al-Dhekri H; Al Ghonaium A; Speckmann C; Fischer A; Mahlaoui N; Nichols KE; Grunebaum E; Al Zahrani D; Roifman CM; Boelens J; Davies EG; Cavazzana-Calvo M; Notarangelo L; Gaspar HB;
Blood; 2012 Oct; 120(17):3615-24; quiz 3626. PubMed ID: 22791287
[TBL] [Abstract][Full Text] [Related]
28. Graft Versus Host Disease Following HLA-Matched Sibling Donor Compared with Matched Related Donor for Hematopoietic Stem Cell Transplantation for the Treatment of Severe Combined Immunodeficiency Disease.
Al-Saud B; Al-Saleem A; Al Rasheed B; Al-Ghonaium A; Al-Ahmari A; Al-Mousa H; Al-Seraihy A; Arnaout R; Al-Jefri A; Elshorbagi S; Elsayed N; Al-Dhekri H; Ayas M; Al-Muhsen S
J Clin Immunol; 2019 May; 39(4):414-420. PubMed ID: 31041574
[TBL] [Abstract][Full Text] [Related]
29. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
[TBL] [Abstract][Full Text] [Related]
30. Societal value of newborn screening for severe combined immune deficiency in Arkansas: An economic analysis.
Hays LH
Public Health Nurs; 2019 Jul; 36(4):541-544. PubMed ID: 30945355
[TBL] [Abstract][Full Text] [Related]
31. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
32. Clinical Features and HSCT Outcome for SCID in Turkey.
Ikinciogullari A; Cagdas D; Dogu F; Tugrul T; Karasu G; Haskologlu S; Aksoylar S; Uygun V; Kupesiz A; Yildiran A; Gursel O; Ates C; Elhan A; Kansoy S; Yesilipek A; Tezcan I;
J Clin Immunol; 2019 Apr; 39(3):316-323. PubMed ID: 30924026
[TBL] [Abstract][Full Text] [Related]
33. A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening.
Al Sukaiti N; Ahmed K; Alshekaili J; Al Kindi M; Cook MC; Farsi TA
Front Immunol; 2020; 11():623199. PubMed ID: 33519828
[TBL] [Abstract][Full Text] [Related]
34. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M; Bartoshesky LE; Bonilla FA; Brokopp C; Brooks E; Caggana M; Celestin J; Church JA; Comeau AM; Connelly JA; Cowan MJ; Cunningham-Rundles C; Dasu T; Dave N; De La Morena MT; Duffner U; Fong CT; Forbes L; Freedenberg D; Gelfand EW; Hale JE; Hanson IC; Hay BN; Hu D; Infante A; Johnson D; Kapoor N; Kay DM; Kohn DB; Lee R; Lehman H; Lin Z; Lorey F; Abdel-Mageed A; Manning A; McGhee S; Moore TB; Naides SJ; Notarangelo LD; Orange JS; Pai SY; Porteus M; Rodriguez R; Romberg N; Routes J; Ruehle M; Rubenstein A; Saavedra-Matiz CA; Scott G; Scott PM; Secord E; Seroogy C; Shearer WT; Siegel S; Silvers SK; Stiehm ER; Sugerman RW; Sullivan JL; Tanksley S; Tierce ML; Verbsky J; Vogel B; Walker R; Walkovich K; Walter JE; Wasserman RL; Watson MS; Weinberg GA; Weiner LB; Wood H; Yates AB; Puck JM; Bonagura VR
JAMA; 2014 Aug; 312(7):729-38. PubMed ID: 25138334
[TBL] [Abstract][Full Text] [Related]
35. Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey.
Chan A; Scalchunes C; Boyle M; Puck JM
Clin Immunol; 2011 Jan; 138(1):3-8. PubMed ID: 21035402
[TBL] [Abstract][Full Text] [Related]
36. Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening.
Soomann M; Prader S; Pinto Monteiro A; Zeilhofer U; Hauri-Hohl M; Güngör T; Pachlopnik Schmid J; Trück J; Felber M
J Clin Immunol; 2024 Jan; 44(1):39. PubMed ID: 38165471
[TBL] [Abstract][Full Text] [Related]
37. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
Auletta JJ; Kou J; Chen M; Bolon YT; Broglie L; Bupp C; Christianson D; Cusatis RN; Devine SM; Eapen M; Hamadani M; Hengen M; Lee SJ; Moskop A; Page KM; Pasquini MC; Perez WS; Phelan R; Riches ML; Rizzo JD; Saber W; Spellman SR; Stefanski HE; Steinert P; Tuschl E; Yusuf R; Zhang MJ; Shaw BE
Transplant Cell Ther; 2023 Jun; 29(6):346.e1-346.e10. PubMed ID: 36924931
[TBL] [Abstract][Full Text] [Related]
38. Primary Immune Deficiency Treatment Consortium (PIDTC) update.
Griffith LM; Cowan MJ; Notarangelo LD; Kohn DB; Puck JM; Shearer WT; Burroughs LM; Torgerson TR; Decaluwe H; Haddad E;
J Allergy Clin Immunol; 2016 Aug; 138(2):375-85. PubMed ID: 27262745
[TBL] [Abstract][Full Text] [Related]
39. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation.
Puck JM;
J Allergy Clin Immunol; 2007 Oct; 120(4):760-8. PubMed ID: 17931561
[TBL] [Abstract][Full Text] [Related]
40. Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts.
Hale JE; Platt CD; Bonilla FA; Hay BN; Sullivan JL; Johnston AM; Pasternack MS; Hesterberg PE; Meissner HC; Cooper ER; Barmettler S; Farmer JR; Fisher D; Walter JE; Yang NJ; Sahai I; Eaton RB; DeMaria A; Notarangelo LD; Pai SY; Comeau AM
J Allergy Clin Immunol Pract; 2021 May; 9(5):2060-2067.e2. PubMed ID: 33607339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
